Listed

Scilex Holding Co

SCLXNasdaqCIK 1820190HealthcareFiscal year ends Dec 31

Reports and events: 215 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Scilex Holding Co, Reports and events
FiledFormWhat it isAccession number
2023-06-2217:56 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-171344
2023-06-2021:52 ETS-1/ARegistration statement, amended0001193125-23-169259
2023-06-0506:07 ETS-1/ARegistration statement, amended0001193125-23-160231
2023-06-0109:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-158495
2023-05-2321:06 ETS-1/ARegistration statement, amended0001193125-23-150788
2023-05-1216:01 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021743
2023-05-0516:49 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-137199
2023-05-0312:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-133984
2023-04-2621:53 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-116108
2023-04-2117:20 ETS-1Registration statement0001193125-23-110713
2023-04-2016:26 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-23-108354
2023-04-1116:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-23-097796
2023-04-1017:15 ETS-1Registration statement0001193125-23-096647
2023-04-0309:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-089024
2023-03-2116:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-075731
2023-03-0816:17 ETDEF 14AProxy statementPeriod 2023-04-060001193125-23-064537
2023-03-0717:11 ET10-KAnnual reportPeriod 2022-12-310000950170-23-006493
2023-03-0309:10 ETSC 13D/AOwnership report, active investor, amended0001193125-23-059136
2023-03-0106:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-055030
2023-02-1316:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-035934
2023-02-0916:06 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-23-030002
2023-02-0606:05 ET8-K5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-024777
2023-02-0216:29 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-022773
2023-02-0209:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-022210
2023-01-3006:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-018205
2023-01-2316:33 ETSC 13D/AOwnership report, active investor, amended0001193125-23-013193
2023-01-1713:52 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-009256
2023-01-1216:45 ETS-1Registration statement0001193125-23-007234
2023-01-0906:04 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-23-004041
2023-01-0309:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-000315
2022-12-2019:47 ETS-1/ARegistration statement, amended0001193125-22-308547
2022-11-3016:09 ETS-1Registration statement0001193125-22-295391
2022-11-3016:05 ETS-1Registration statement0001193125-22-295370
2022-11-1820:34 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-22-287974
2022-11-1717:09 ETSC 13DOwnership report, active investor0001193125-22-287802
2022-11-1717:05 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-287783
2022-11-0917:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-116569
2022-11-0416:01 ET10-QQuarterly reportPeriod 2022-09-300001213900-22-069366
2022-10-3107:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-112677
2022-10-1816:55 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-109728
2022-09-1420:33 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-22-099785
2022-08-1216:10 ET10-QQuarterly reportPeriod 2022-06-300001213900-22-047404
2022-07-0509:21 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-036989
2022-06-0708:44 ETDEF 14AProxy statementPeriod 2022-06-300001213900-22-031478
2022-05-2316:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-028923
2022-05-1616:01 ET10-QQuarterly reportPeriod 2022-03-310001213900-22-027064
2022-04-1117:00 ET8-K/A2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-019222
2022-04-1108:01 ET8-K2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-019090
2022-03-2121:40 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-22-013697
2022-02-2416:31 ET10-KAnnual reportPeriod 2021-12-310001213900-22-009229

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.